Perimenopause Symptom Checklist: 34 Signs to Watch For

What Is Perimenopause and When Does It Start?

Perimenopause is the transitional phase in which ovarian reserve declines, ovulation becomes irregular, and the hormonal milieu shifts — beginning years before the final menstrual period that formally marks menopause. The American College of Obstetricians and Gynecologists (ACOG) defines menopause as 12 consecutive months without a period; everything leading up to that point is perimenopause. Most women do not realize they are in perimenopause because symptoms precede irregular cycles by months or even years.

The Stages of Reproductive Aging Workshop (STRAW+10) — the most widely adopted clinical staging system for reproductive aging, published in Menopause in 2012 — divides the transition into early and late perimenopause based on cycle variability. Early perimenopause begins when cycle length varies by 7 or more days from the typical length. Late perimenopause is marked by 60-day or longer gaps between periods. This staging matters because symptom patterns, hormonal profiles, and recommended lab tests differ across stages.

Average onset by the numbers:

One frequently overlooked detail: progesterone declines before estrogen does. In early perimenopause, progesterone often falls because ovulation becomes inconsistent — even when estrogen remains relatively normal. This progesterone-first decline causes the symptom cluster of sleep disruption, anxiety, and heavier periods that many women experience years before hot flashes appear. Progesterone acts on GABA receptors (the same receptors targeted by benzodiazepines) through its metabolite allopregnanolone; its loss disrupts sleep architecture and emotional regulation in ways that are often attributed to stress or aging rather than hormonal change.

Risk factors for earlier perimenopause onset include smoking (associated with 1–2 years earlier onset, per data published in Obstetrics and Gynecology), shorter cycle length in reproductive years, family history, lower body weight, certain autoimmune conditions, and chemotherapy or pelvic radiation history. If you experienced early puberty, some evidence suggests earlier perimenopause onset as well, though this relationship is less robust.

The Full 34-Symptom Perimenopause Checklist

The North American Menopause Society recognizes 34 symptoms associated with menopause and the perimenopause transition; the list below is organized by clinical category to help you identify patterns rather than reviewing isolated symptoms. Check any symptom you have experienced in the past 3 months, noting whether it is new or has worsened compared to your baseline.

Category 1: Menstrual Changes
These are typically the first signs of perimenopause, driven by irregular ovulation and declining progesterone.

• Shorter cycles (less than 25 days) — often the earliest sign, appearing years before other symptoms
• Longer cycles, missed periods, or skipped periods
• Heavier periods or flooding (increased flow, passing clots)
• Lighter or shorter periods
• Spotting between periods
• Worsening PMS or new-onset PMDD

Category 2: Vasomotor Symptoms
Hot flashes and night sweats are the hallmark perimenopausal symptoms, caused by estrogen fluctuations disrupting the hypothalamic thermostat (the KNDy neuron network). SWAN data published in Menopause (Avis et al., 2015) found vasomotor symptoms lasted a median of 7.4 years, with African American women experiencing significantly longer duration.

• Hot flashes (sudden waves of heat, typically lasting 1–5 minutes)
• Night sweats (hot flashes occurring during sleep)
• Chills following hot flashes
• Heart palpitations during hot flashes or at rest

Category 3: Mood and Cognitive Symptoms
Estrogen modulates serotonin, dopamine, and norepinephrine pathways; progesterone affects GABA. Fluctuations in both hormones affect mood regulation and cognitive performance. A 2018 study in JAMA Psychiatry (Maki et al.) found that the risk of clinical depression is 1.5–3x higher during perimenopause than in premenopause, even in women with no prior psychiatric history.

• Irritability or mood swings
• Anxiety, nervousness, or feeling on edge (new onset or worsened)
• Low mood or depressive symptoms
• Brain fog — difficulty concentrating, word-finding problems, or mental slowness
• Memory lapses (forgetting names, appointments, or where you placed items)
• Decreased motivation or anhedonia

Category 4: Physical and Metabolic Symptoms
These symptoms often emerge later in perimenopause as estrogen decline becomes more pronounced, affecting body composition, connective tissue, and metabolic function.

• Weight gain, particularly around the abdomen, without changes in diet or exercise
• Joint pain or stiffness (arthralgia) — often in hands, knees, or shoulders; driven by estrogen's anti-inflammatory role
• Headaches or migraines, new onset or worsened
• Breast tenderness
• Thinning hair or increased hair shedding
• Dry or itchy skin
• Formication (crawling or tingling sensation under the skin — an under-recognized perimenopause symptom)
• Changes in body odor
• Fatigue that is disproportionate to activity and not relieved by sleep

Category 5: Sleep Symptoms
Sleep disruption in perimenopause has at least two distinct mechanisms: night sweats waking you from sleep, and progesterone-mediated changes to sleep architecture independent of temperature. A 2020 study in Sleep Medicine Reviews found that 39–47% of perimenopausal women report clinically significant insomnia, compared to 31% of premenopausal women.

• Difficulty falling asleep (sleep onset insomnia)
• Waking in the middle of the night and difficulty returning to sleep
• Unrefreshing sleep — waking tired despite adequate hours in bed
• Vivid dreams or nightmares
• Restless legs syndrome (new onset or worsened; estrogen modulates dopaminergic pathways involved in RLS)

Category 6: Sexual and Genitourinary Symptoms
The Genitourinary Syndrome of Menopause (GSM) — the clinical term for vulvovaginal and urinary symptoms — can begin in perimenopause, not just after menopause. Because estrogen receptors are dense in the vulva, vagina, urethra, and bladder, declining estrogen affects all of these tissues. Unlike vasomotor symptoms, GSM does not resolve without treatment and typically worsens over time.

• Vaginal dryness
• Painful intercourse (dyspareunia)
• Decreased libido or sexual interest
• Urinary urgency or increased frequency
• Recurrent urinary tract infections (UTIs) — estrogen deficiency alters vaginal pH, disrupting protective flora

Your symptom count: Mark the total number checked in each category below:

How to Score Your Checklist: What Counts as Perimenopause?

No single symptom score definitively diagnoses perimenopause, because perimenopause is primarily a clinical and hormonal diagnosis — but your checklist results, combined with age and cycle history, can strongly suggest whether the menopause transition is underway.

Interpreting your checklist results:

The FSH limitation most checklists don't mention: FSH (follicle-stimulating hormone) is the standard screening test for perimenopause, but it has a critical flaw in early and mid-perimenopause: FSH fluctuates enormously from cycle to cycle. The Endocrine Society and NAMS both note that a single elevated FSH reading does not confirm perimenopause, and a single normal reading does not rule it out. SWAN data demonstrate that FSH can read as normal in a given cycle even as a woman experiences significant perimenopausal symptoms — because estrogen surges can suppress FSH transiently. For women in early perimenopause who still cycle, FSH is most informative when drawn on days 2–5 of the menstrual cycle AND repeated across multiple cycles if the first result is inconclusive.

Anti-Müllerian hormone (AMH), produced by ovarian follicles, is a more stable marker of ovarian reserve and declines continuously through perimenopause regardless of cycle phase. A 2020 study in Human Reproduction (Tehrani et al.) found AMH was more reliable than FSH for predicting proximity to the final menstrual period. AMH below 0.5 ng/mL correlates with late perimenopause. Your hormone testing guide covers when to draw each marker and which values indicate perimenopause at different stages.

Symptom severity scales: If your clinician uses a validated tool, the two most common are the Menopause Rating Scale (MRS), which scores 11 symptoms from 0 to 4, and the Greene Climacteric Scale, which scores 21 symptoms. Total MRS scores above 16 indicate severe symptom burden warranting treatment consideration. The checklist on this page maps to the same clinical categories used by both tools.

What to Do Next: Hormone Testing and What to Tell Your Doctor

If your checklist suggests perimenopause, the most productive next step is a targeted hormone panel drawn at the correct time in your cycle — because the timing of blood draws determines whether results are interpretable or misleading.

The recommended hormone panel for perimenopause evaluation:

What to tell your doctor: Many clinicians remain undertrained in perimenopause management. Come prepared with a written symptom log covering duration, frequency, and severity. The NAMS recommends that women bring the following information to the consultation: date of last normal period, cycle regularity over the past 12 months, sleep hours and quality, mood changes with approximate onset, and any first-degree family history of early menopause. If your provider dismisses your symptoms based on a single normal FSH reading, it is appropriate to request repeat testing across two menstrual cycles, as well as AMH and a progesterone level drawn at day 21.

Women with predominantly metabolic symptoms — abdominal weight gain, fatigue, or insulin resistance symptoms — may benefit from a combined metabolic and hormonal evaluation. SWAN data show that women with the highest insulin resistance at baseline experienced the most severe vasomotor symptom burden through perimenopause, suggesting that improving metabolic health may reduce symptom severity independent of hormone therapy. Explore our comprehensive hormone testing guide or take our metabolic and hormone assessment to identify which panels are most relevant to your symptom pattern.

Perimenopause vs. Conditions With Similar Symptoms

Perimenopause symptoms overlap substantially with several common conditions, and misattribution in either direction — dismissing hormonal symptoms as anxiety, or attributing a thyroid disorder to perimenopause — leads to delayed and inappropriate treatment.

The non-obvious insight: The link between perimenopause and newly unmasked ADHD is one of the most underrecognized clinical phenomena in women's health. Estrogen upregulates dopamine and serotonin receptor sensitivity; when estrogen fluctuates and declines, women who previously coped with subclinical attention difficulties — often through high intelligence and behavioral compensation — find those strategies no longer work. A 2023 review in Menopause (Epperson et al.) identified this as a priority research area, noting that perimenopausal cognitive complaints attributed to brain fog may include a distinct ADHD subgroup for whom estrogen therapy has direct dopaminergic mechanisms. If your dominant symptom cluster is cognitive — and especially if you recall always having some degree of attention or organization difficulty — this distinction is worth raising with your provider.

Ready to identify your specific hormonal and metabolic profile? Take our free metabolic and hormone assessment or explore our hormone testing guide for a step-by-step lab ordering protocol tailored to perimenopausal women.